Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CellFX® System

K-Number: K221671 · 2022-08-01

Decision Date2022-08-01
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

CellFX® System is a medical device manufactured by Pulse Biosciences, Inc.. It received FDA 510(k) clearance on 2022-08-01 under approval number K221671. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CellFX® System?

CellFX® System is a medical device that received FDA 510(k) clearance on 2022-08-01. It is manufactured by Pulse Biosciences, Inc.. The 510(k) number is K221671.

When was CellFX® System approved by the FDA?

CellFX® System received FDA 510(k) clearance on 2022-08-01, under approval number K221671.

What company makes CellFX® System?

CellFX® System is manufactured by Pulse Biosciences, Inc..

What is the FDA product code for CellFX® System?

The FDA product code for CellFX® System is GEI.

Related Clinical Trials

Other Devices by Pulse Biosciences, Inc.

View all 7 devices →

Related Devices (Code: GEI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.